Riskpilot← Back to searchSign inGet full accessTento Medical AB
ABActiveOrg 5569156036Cementgatan 25Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20125-9 employees
Revenue 2024
SEK 1,8M
-16% vs 2023
EBITDA margin
-2.4%
-32% vs 2023
Equity ratio
59.4%
Financial strength
Net profit 2024
SEK 40K
+116% vs 2023
| Revenue | SEK 1,8M | -16% |
| EBITDA | SEK -43K | -32% |
| Net profit | SEK 40K | +116% |
| Total assets | SEK 2,2M | -9% |
| Equity | SEK 1,3M | +3% |
| Employees | — | — |
Legal name
Tento Medical AB
Org number
5569156036
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
17 december 2012
Share capital
SEK 50 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall idka försäljning av in vitro diagnostiska produker för hemmabruk och professionellt bruk och därmed förenlig verksamhet.
Address
Cementgatan 25
Phone
+46705911496
Email
0705911496.rn@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 278 | 3 912 | 2 965 | 2 177 | 1 828 |
| Staff expenses | — | — | −118 | −134 | −71 |
| EBITDA | −13 | 163 | 45 | −33 | −43 |
| Depreciation & amort. | −5 | −0 | — | — | — |
| EBIT | −18 | 163 | 45 | −33 | −43 |
| Net financials | −1 | −1 | — | −222 | 3 |
| Profit before tax | 34 | 133 | 25 | −245 | 60 |
| Tax | −13 | −32 | −12 | −1 | −19 |
| Net profit | 21 | 101 | 13 | −245 | 40 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 360 | 2 243 | 2 313 | 2 399 | 2 182 |
| Equity | 1 786 | 1 888 | 1 900 | 1 255 | 1 295 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 350 | 104 | 141 | 882 | 724 |
| Total debt | 350 | 104 | 141 | 882 | 724 |
EBITDA margin
-2.4%
This company
15.8%
Market median
-115% vs market
20202024
Equity ratio
59.4%
This company
38.2%
Market median
+55% vs market
20202024
Return on equity
3.1%
This company
18.4%
Market median
-83% vs market
20202024
Net profit margin
2.2%
This company
8.1%
Market median
-73% vs market
20202024
Asset turnover
0.84×
This company
1.12×
Market median
+25% vs market
20202024
Debt / equity
0.68×
This company
0.62×
Market median
+10% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PO Chief Auditor | Chief Auditor | 2022 |
| Former (1) | ||
BÅ Chief Auditor | Chief Auditor | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2026 | |
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Former (2) | ||
| Board of Directors | 2021 – 2024 | |
| Board of Directors | 2021 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tento Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pär-Ola Olsson | Chief Auditor | 0 companies |
| Bengt Åke Olsson | Chief Auditor | 0 companies |
| Patrik Tobias Dahlskog | Board of Directors | 0 companies |
| Victor Maximilian Lenormand Nilsson | Deputy Board Member | 0 companies |
| Mirko Mario Mastio | Board of Directors | 0 companies |
| Anders Rickard Nilsson | Chairman | 0 companies |
| Jonny Björn Peter Rosengren | Board of Directors | 0 companies |